A new gene therapy could be groundbreaking for patients with severe anemia. The costs? $2.8 million.

A new gene therapy called Zynteglo could make iron-rich blood transfusions unnecessary to treat patients with beta-thalassemia, which causes severe anemia, but costs around $2.8 million. Anne Thompson from CNNBreakingNews.net shares more about the price of gene therapy and why the experts say it’s just a sign of things to come. December 24, 2022